Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$95,262,760
-$3,233,503 QoQ
Shares Held
754,019
+6.7% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#151
of 2,266 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewEdge Wealth, LLC holds $502,588,092 across 13 Drug Manufacturers - General names. GILD ranks #2 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
422,116 | $106,221,270 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
754,019 | $95,262,760 | |
| 3 | NVS |
Novartis AG
|
579,486 | $90,817,045 | |
| 4 | LLY |
ELI LILLY & Co
|
64,986 | $77,946,164 | |
| 5 | JNJ |
Johnson & Johnson
|
255,223 | $64,818,985 | |
| 6 | AMGN |
Amgen Inc
|
110,074 | $39,859,996 | |
| 7 | MRK |
Merck & Co., Inc.
|
64,900 | $8,339,650 | |
| 8 | AZN |
Astrazeneca PLC
|
33,124 | $6,280,972 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,262,760 | 754,019 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $98,496,263 | 706,725 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $79,347,727 | 646,470 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $68,785,590 | 619,690 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $66,788,753 | 602,406 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $48,432,604 | 432,241 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $37,392,946 | 404,817 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $31,404,284 | 374,574 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $25,419,113 | 370,487 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $27,646,747 | 377,430 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $27,540,726 | 339,967 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $23,410,881 | 312,395 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $20,443,434 | 265,258 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $15,268,720 | 184,027 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,408,082 | 86,291 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,084,304 | 82,417 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,541,475 | 105,832 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,322,371 | 72,706 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,834,155 | 66,577 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,300,385 | 61,566 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||